Aducanumab: A Deep Dive into BIIB037 and its Impact The medication, originally known as BIIB037, represents a notable effort to combat emerging Alzheimer's disease. Designed by Biogen, the treatment works by targeting https://idavvfr015208.blogdigy.com/text-66424728